Bibliographic information
Recommendation
Infants weighing < 5 kg with uncomplicated P. falciparum malaria should be treated with an ACT at the same mg/kg bw target dose as for children weighing 5 kg. *Not evaluated using the GRADE framework
Recommended in favor
Strong
Notes and Remarks
Practical info The pharmacokinetics properties of many medicines in infants differ markedly from those in adults because of the physiological changes that occur in the first year of life. Accurate dosing is particularly important for infants. The only antimalarial agent that is currently contraindicated for infants (< 6 months) is primaquine. ACT is recommended and should be given according to body weight at the same mg/kg bw dose for all infants, including those weighing < 5 kg, with close monitoring of treatment response. The lack of infant formulations of most antimalarial drugs often necessitates division of adult tablets, which can lead to inaccurate dosing. When available, paediatric formulations and strengths are preferred, as they improve the effectiveness and accuracy of ACT dosing.